Peptide Partners
7 tests · avg lab score 8.9/10
Latest Finnrick test Nov 10, 2025
Selective growth hormone secretagogue with minimal side effects.
Grade
Finnrick lab signal
Lowest
Trust
Lowest price first, with Finnrick grades in the same row so cost never gets divorced from lab context.
We highlight current purity and quantity results without implying every vendor or every batch has been tested equally.
Purity distribution
No Finnrick test results are attached to this peptide yet.
Peptide Partners
7 tests · avg lab score 8.9/10
Latest Finnrick test Nov 10, 2025
Paradigm Peptide
4 tests · avg lab score 9.1/10
Latest Finnrick test Nov 1, 2025
The current schema gives us a trustworthy live market snapshot. It does not yet store price snapshots over time, so the chart module stays honest about that gap.
Historical pricing
The current schema stores live prices but not historical snapshots yet, so this page shows current market comparison rather than pretending time-series data exists. Once snapshots are recorded, this module can render 30-, 90-, and 180-day trends honestly.
The goal is to keep market data inside a broader research and safety frame, not let the price table become the whole story.
Ipamorelin is a selective growth hormone secretagogue that triggers pulsatile GH release without significant cortisol or prolactin elevation. Not FDA-approved; WADA-prohibited.
Read the full research guide →Research information only
Peptide Daily is an informational resource only. Peptide research chemicals are not approved for human use by the FDA unless otherwise noted. Nothing on this site constitutes medical advice. Consult a qualified healthcare provider before using any peptide or research chemical.